Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes

Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes English

This Activity for

  • Pharmacy
  • Clinical Pharmacy

What I will learn?

•Understand the mechanism of action of Mounjaro, a once-weekly, first-in-class GIP and GLP-1 receptor agonist for chronic weight management and type 2 diabetes.
•Review the efficacy and safety of Mounjaro in chronic weight management and type 2 diabetes.
•Review the efficacy superiority of Tirzepatide compared with Semaglutide in chronic weight management.
•Discuss the safe and effective use of Mounjaro.

Additional items to the activity

Optional Details Type Fee
Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes Certificate

Certificate

Certificate Free
VAT 15% Included

About Organizer

Contact the organizer and they will be glad to help!

Virtual Medical Academy

was 0 SAR

Free
0%coupon Discount
  • calendar 15 Sep 2025
  • clock 08:00 pm - 10:00 pm - Saudi Arabia (+03:00)
  • quality Certificate Available
  • adjust no access Materiel
  • Registration Policy Full Course
  • Completion Role You must attend all the Sessions
  • Refund Policy No Refund
Free